These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26498282)

  • 1. Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia.
    Qi YF; Zhang J; Wang L; Shenoy V; Krause E; Oh SP; Pepine CJ; Katovich MJ; Raizada MK
    J Mol Med (Berl); 2016 Jan; 94(1):37-49. PubMed ID: 26498282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group box 1 protein, angiotensins, ACE2, and target organ damage.
    Luft FC
    J Mol Med (Berl); 2016 Jan; 94(1):1-3. PubMed ID: 26658521
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
    Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arg972 Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidence.
    Liu W; Zhou X; Yu F; Hu J; Hu W
    Cardiovasc Diabetol; 2013 Oct; 12():151. PubMed ID: 24134599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury.
    Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F
    PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.
    Qi Y; Shenoy V; Wong F; Li H; Afzal A; Mocco J; Sumners C; Raizada MK; Katovich MJ
    Exp Physiol; 2011 Sep; 96(9):863-74. PubMed ID: 21685447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology.
    Der Sarkissian S; Grobe JL; Yuan L; Narielwala DR; Walter GA; Katovich MJ; Raizada MK
    Hypertension; 2008 Mar; 51(3):712-8. PubMed ID: 18250366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury.
    Fang F; Liu GC; Zhou X; Yang S; Reich HN; Williams V; Hu A; Pan J; Konvalinka A; Oudit GY; Scholey JW; John R
    PLoS One; 2013; 8(8):e71433. PubMed ID: 23951161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice.
    Kitahara T; Takeishi Y; Harada M; Niizeki T; Suzuki S; Sasaki T; Ishino M; Bilim O; Nakajima O; Kubota I
    Cardiovasc Res; 2008 Oct; 80(1):40-6. PubMed ID: 18558628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
    Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
    Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity.
    Patel VB; Mori J; McLean BA; Basu R; Das SK; Ramprasath T; Parajuli N; Penninger JM; Grant MB; Lopaschuk GD; Oudit GY
    Diabetes; 2016 Jan; 65(1):85-95. PubMed ID: 26224885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin D1 Attenuates Myocardial Infarction in a Rodent Model with the Participation of the HMGB1 Pathway.
    Liu R; Li Z; Wang Q
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):399-406. PubMed ID: 31280453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis.
    Ding HS; Yang J; Chen P; Yang J; Bo SQ; Ding JW; Yu QQ
    Gene; 2013 Sep; 527(1):389-93. PubMed ID: 23727604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyromonas Gingivalis Elevated High-Mobility Group Box 1 Levels After Myocardial Infarction in Mice.
    Srisuwantha R; Shiheido Y; Aoyama N; Sato H; Kure K; Laosrisin N; Izumi Y; Suzuki JI
    Int Heart J; 2017 Oct; 58(5):762-768. PubMed ID: 28966323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction increases ACE2 expression in rat and humans.
    Burrell LM; Risvanis J; Kubota E; Dean RG; MacDonald PS; Lu S; Tikellis C; Grant SL; Lew RA; Smith AI; Cooper ME; Johnston CI
    Eur Heart J; 2005 Feb; 26(4):369-75; discussion 322-4. PubMed ID: 15671045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 deficiency protects the heart against myocardial infarction injury in mice via the P53/HMGB1 pathway.
    Liu Y; Chen L; Gao L; Pei X; Tao Z; Xu Y; Li R
    Free Radic Biol Med; 2022 Oct; 191():119-127. PubMed ID: 36055602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.
    Du M; Yang W; Schmull S; Gu J; Xue S
    Int Immunopharmacol; 2020 Jan; 78():106055. PubMed ID: 31816575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.